Journal article icon

Journal article

Leveraging crowdsourcing to facilitate the discovery of new medicines.

Abstract:
Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. The new PPP Arch2POCM hopes to foster biomedical innovation through precompetitive validation of pioneer therapeutic targets for human diseases. In this meeting report, we capture insights garnered from the April 2011 Arch2POCM conference.
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Genomics Consortium
Role:
Author
Journal:
Science translational medicine
Volume:
3
Issue:
88
Pages:
88mr1
Publication date:
2011-06-01
DOI:
EISSN:
1946-6242
ISSN:
1946-6234
Source identifiers:
154579
Language:
English
Keywords:
Pubs id:
pubs:154579
UUID:
uuid:d877097f-a344-41a8-9ef5-9ed0faea7bb2
Local pid:
pubs:154579
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP